Stockreport

Arrowhead Pharmaceuticals Stock Climbs on Plans To Seek FDA Approval for New Drug [Yahoo! Finance]

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations
PDF The drug, called Plozasiran, helped patients with familial chylomicronemia syndrome (FCS), which has no currently approved treatment. Arrowhead said it plans to file [Read more]